Trial Profile
Immunoglobulin (Privigen) Therapy to Treat BK Viremia and Prevent Alloimmune Activation in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Polyomavirus infections; Viraemia
- Focus Therapeutic Use
- 02 Sep 2021 Status changed from active, no longer recruiting to completed.
- 17 Aug 2020 Planned End Date changed from 1 Dec 2019 to 1 Feb 2021.
- 17 Aug 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.